Camazepam
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Camazepam
|
|
| Systematic (IUPAC) name | |
| (9-chloro-2-methyl-3-oxo-6-phenyl- 2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-4-yl) N,N-dimethylcarbamate |
|
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H18ClN3O3 |
| Mol. mass | 371.8 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Camazepam (marketed under the brand names Albego, Limpidon, and Paxor) is the dimethyl carbamate ester of temazepam, a metabolite of diazepam. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Compared to temazepam, camazepam has shown roughly equal anxiolytic properties, and less anticonvulsant, sedative and motor-impairing properties.
[edit] External links
|
|||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
